Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Patent
1987-06-05
1989-05-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
514708, 514731, A61K 3105, A61K 3110, A61K 31095
Patent
active
048351903
ABSTRACT:
The compounds of the present invention comprise substituted phenolic thioether derivatives that are specific inhibitors of 5-lipoxygenase and which, therefore, are useful in the treatment of local and systemic inflammation, allergy and hypersensitivity reactions and other disorders in which agents formed in the 5-lipoxygenase metabolic pathway are involved.
REFERENCES:
patent: 3886285 (1975-05-01), Bentley et al.
patent: 4012523 (1977-03-01), Wagner
patent: 4029812 (1977-06-01), Wagner et al.
patent: 4076841 (1978-02-01), Wagner et al.
patent: 4078084 (1978-03-01), Wagner et al.
patent: 4128530 (1978-12-01), Cottman et al.
patent: 4143076 (1979-03-01), Cottman et al.
patent: 4153803 (1979-05-01), Thiele et al.
Chem. Abst. 89 (1978)-27167j.
Chem. Abst. 94 (1981)-30290c.
M. B. Neuworth, J. Med. Chem, 13 (4): 722-5.
Chem. Abst. 76:109226y; vol. 76 (1972).
Chem. Abst. 84:6258w; vol. 84 (1976).
Chem. Abst. 83: 27876r, vol. 83 (1975).
Samuelsson, "Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation", Science, v. 220, 1983, pp. 568-570.
Bach, "Inhibitors of Leukotrinee Synthesis and Action", The Leukotrienes, Chemistry and Biology, Academic Press, pp. 163-194 (1984).
Lee et al., "Human Biology and Immunoreactivity of Leukotrienes", Advances in Inflammation Research, vol. 6, pp. 219-225, Raven Press (1984).
Editorial, "Leukotrienes and Other Lipoxygenase Products in the Pathegonesis and Therapy of Psoriasis and Dermatoses", Arch. Dermatol., vol. 119, pp. 541-547 (Jul. 1983).
Lewis et al., "A Review of Recent Contributions on Biologically Active Products of Arachidonate Conversion", Int. J. Immunopharma. vol. 4, No. 2, pp. 85-90 (1982).
Bach, "Prospects for the Inhibition of Leukotriene Synthesis", Biochemical Pharmacology, vol. 33, No. 4, pp. 515-521 (1984).
Becker, "Chemotactic Factors of Inflammation", pp. 223-225 (Elsevier Science Publishers, B.V. Amsterdam, 1983).
Sharon et al., "Enhanced Synthesis of Leukotriene B.sub.4 by Colonic Mucosa in Inflammatory Bowel Disease", Gastroenterology, vol. 86, pp. 453-460 (1984).
Musch et al., "Stimulation of Colonic Secretion by Lipoxygenase Metabolites of Arachidonic Acid", Science, vol. 217, p. 1255 (1982).
Khim. Khim. Tekhnol. 20, (4), pp. 568-574 (1977).
Mueller Richard A.
Partis Richard A.
Friedman Stanley J.
G. D. Searle & Co.
Henderson R. E. L.
Kanady Mary Jo
Matukaitis Paul D.
LandOfFree
Phenolic thioethers as inhbitors of 5-lipoxygenase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenolic thioethers as inhbitors of 5-lipoxygenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenolic thioethers as inhbitors of 5-lipoxygenase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2153016